Atlas Trials

Determine the Bioavailability of Selegiline TDS 6mg/24 Hours vs EMSAM in Healthy Subjects

Clinical trial NCT06607744 · COMPLETED

Trial details

NCT number
NCT06607744
Sponsor
Corium Innovations, Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
MDD
Start date
2025-02-10
Primary completion
2025-03-25
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.